These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 6201257

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of hairy cell leukemia with alternating cycles of pentostatin and recombinant leukocyte A interferon: results of a phase II study.
    Martin A, Nerenstone S, Urba WJ, Longo DL, Lawrence JB, Clark JW, Hawkins MJ, Creekmore SP, Smith JW, Steis RG.
    J Clin Oncol; 1990 Apr; 8(4):721-30. PubMed ID: 2313337
    [Abstract] [Full Text] [Related]

  • 6. Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatment.
    Bastie JN, Cazals-Hatem D, Daniel MT, D'Agay MF, Rabian C, Glaisner S, Noel-Walter MP, Dabout D, Flandrin G, Dombret H, Poisson D, Degos L, Castaigne S.
    Leuk Lymphoma; 1999 Nov; 35(5-6):555-65. PubMed ID: 10609793
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S, Camós M, López-Guillermo A, Bosch F, Cervantes F, Blandé J, Esteve J, Cobo F, Nomdedeu B, Campo E, Montserrat E.
    Cancer; 2000 May 01; 88(9):2142-8. PubMed ID: 10813727
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intensive chemotherapy of hairy cell leukemia in patients with aggressive disease.
    Calvo F, Castaigne S, Sigaux F, Marty M, Degos L, Boiron M, Flandrin G.
    Blood; 1985 Jan 01; 65(1):115-9. PubMed ID: 3965043
    [Abstract] [Full Text] [Related]

  • 13. Five-year survival of patients with disseminated nonseminomatous testicular cancer treated with cisplatin, vinblastine, and bleomycin.
    Stoter G, Vendrik CP, Struyvenberg A, Sleyfer DT, Vriesendorp R, Schraffordt Koops H, van Oosterom AT, ten Bokkel Huinink WW, Pinedo HM.
    Cancer; 1984 Oct 15; 54(8):1521-4. PubMed ID: 6206937
    [Abstract] [Full Text] [Related]

  • 14. [Classic Hodgkin's lymphoma in post-treatment hairy cell leukemia: report of a case].
    Chen DB, Shen DH.
    Zhonghua Bing Li Xue Za Zhi; 2011 Dec 15; 40(12):848-9. PubMed ID: 22336215
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of malignant germ cell tumors of the ovary with cisplatin, vinblastine, and bleomycin (PVB).
    Vriesendorp R, Aalders JG, Sleijfer DT, Willemse PH, Bouma J, Mulder NH.
    Cancer Treat Rep; 1984 May 15; 68(5):779-81. PubMed ID: 6202407
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Combined antineoplastic and antiretroviral therapy for patients with Hodgkin's disease and human immunodeficiency virus infection. A prospective study of 17 patients. The Italian Cooperative Group on AIDS and Tumors (GICAT).
    Errante D, Tirelli U, Gastaldi R, Milo D, Nosari AM, Rossi G, Fiorentini G, Carbone A, Vaccher E, Monfardini S.
    Cancer; 1994 Jan 15; 73(2):437-44. PubMed ID: 7507401
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.